Calithera Biosciences Valuation
| CALADelisted Stock | USD 0.05 0.00 0.00% |
Calithera Biosciences seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Calithera Biosciences from analyzing the firm fundamentals such as Shares Owned By Insiders of 1.07 %, current valuation of (1.1 M), and Return On Equity of -1.14 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Calithera Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Calithera Biosciences is based on 3 months time horizon. Increasing Calithera Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Calithera Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Calithera Pink Sheet. However, Calithera Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.05 | Real 0.0475 | Hype 0.05 |
The real value of Calithera Pink Sheet, also known as its intrinsic value, is the underlying worth of Calithera Biosciences Company, which is reflected in its stock price. It is based on Calithera Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Calithera Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Calithera Biosciences helps investors to forecast how Calithera pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Calithera Biosciences more accurately as focusing exclusively on Calithera Biosciences' fundamentals will not take into account other important factors: Calithera Biosciences Total Value Analysis
Calithera Biosciences is currently expected to have valuation of (1.1 M) with market capitalization of 341.07 K, debt of 1.67 M, and cash on hands of 41.79 M. The negative valuation of Calithera Biosciences may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Calithera Biosciences fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(1.1 M) | 341.07 K | 1.67 M | 41.79 M |
Calithera Biosciences Asset Utilization
One of the ways to look at asset utilization of Calithera is to check how much profit was generated for every dollar of assets it reports. Calithera Biosciences shows a negative utilization of assets of -0.56 percent, losing $0.005629 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Calithera Biosciences shows how discouraging it operates for each dollar spent on its assets.Calithera Biosciences Ownership Allocation
Almost 72.17 percent of Calithera Biosciences outstanding shares are held by general public with 1.07 (percent) owned by insiders and only 26.76 % by other corporate entities.Calithera Biosciences Profitability Analysis
Net Loss for the year was (39.65 M) with loss before overhead, payroll, taxes, and interest of (42.7 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Calithera Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Calithera Biosciences and how it compares across the competition.
About Calithera Biosciences Valuation
The pink sheet valuation mechanism determines Calithera Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Calithera Biosciences. We calculate exposure to Calithera Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Calithera Biosciences's related companies.Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. Calithera Biosci operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.
8 Steps to conduct Calithera Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Calithera Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Calithera Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Calithera Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Calithera Biosciences' revenue streams: Identify Calithera Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Calithera Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Calithera Biosciences' growth potential: Evaluate Calithera Biosciences' management, business model, and growth potential.
- Determine Calithera Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Calithera Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Calithera Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |